nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—EBP—Azacitidine—Pentostatin—hematologic cancer	0.00239	0.192	CbGdCrCtD
Pentazocine—EBP—Azacitidine—Clofarabine—hematologic cancer	0.00213	0.171	CbGdCrCtD
Pentazocine—EBP—Azacitidine—Nelarabine—hematologic cancer	0.002	0.161	CbGdCrCtD
Pentazocine—EBP—Azacitidine—Fludarabine—hematologic cancer	0.00156	0.125	CbGdCrCtD
Pentazocine—EBP—Azacitidine—Cytarabine—hematologic cancer	0.00148	0.118	CbGdCrCtD
Pentazocine—EBP—Azacitidine—Gemcitabine—hematologic cancer	0.00148	0.118	CbGdCrCtD
Pentazocine—EBP—Azacitidine—Cladribine—hematologic cancer	0.00144	0.115	CbGdCrCtD
Pentazocine—Hypertension—Dexamethasone—hematologic cancer	0.000285	0.000354	CcSEcCtD
Pentazocine—Decreased appetite—Etoposide—hematologic cancer	0.000284	0.000354	CcSEcCtD
Pentazocine—Diarrhoea—Ifosfamide—hematologic cancer	0.000283	0.000352	CcSEcCtD
Pentazocine—Nausea—Vinorelbine—hematologic cancer	0.000283	0.000352	CcSEcCtD
Pentazocine—Asthenia—Mitoxantrone—hematologic cancer	0.000282	0.000351	CcSEcCtD
Pentazocine—Asthenia—Irinotecan—hematologic cancer	0.000282	0.000351	CcSEcCtD
Pentazocine—Vomiting—Thalidomide—hematologic cancer	0.00028	0.000348	CcSEcCtD
Pentazocine—Dizziness—Carmustine—hematologic cancer	0.00028	0.000348	CcSEcCtD
Pentazocine—Constipation—Etoposide—hematologic cancer	0.00028	0.000348	CcSEcCtD
Pentazocine—Dermatitis—Thalidomide—hematologic cancer	0.000277	0.000345	CcSEcCtD
Pentazocine—Dizziness—Alitretinoin—hematologic cancer	0.000277	0.000345	CcSEcCtD
Pentazocine—Diarrhoea—Vincristine—hematologic cancer	0.000276	0.000343	CcSEcCtD
Pentazocine—Headache—Thalidomide—hematologic cancer	0.000276	0.000343	CcSEcCtD
Pentazocine—Sweating—Epirubicin—hematologic cancer	0.000276	0.000343	CcSEcCtD
Pentazocine—Asthenia—Gemcitabine—hematologic cancer	0.000275	0.000342	CcSEcCtD
Pentazocine—Dizziness—Ifosfamide—hematologic cancer	0.000274	0.00034	CcSEcCtD
Pentazocine—Pruritus—Gemcitabine—hematologic cancer	0.000271	0.000337	CcSEcCtD
Pentazocine—Vision blurred—Prednisone—hematologic cancer	0.000271	0.000337	CcSEcCtD
Pentazocine—Nausea—Thiotepa—hematologic cancer	0.00027	0.000336	CcSEcCtD
Pentazocine—Feeling abnormal—Etoposide—hematologic cancer	0.000269	0.000335	CcSEcCtD
Pentazocine—Anaphylactic shock—Betamethasone—hematologic cancer	0.000269	0.000335	CcSEcCtD
Pentazocine—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000269	0.000335	CcSEcCtD
Pentazocine—Diarrhoea—Mitoxantrone—hematologic cancer	0.000269	0.000335	CcSEcCtD
Pentazocine—Diarrhoea—Irinotecan—hematologic cancer	0.000269	0.000335	CcSEcCtD
Pentazocine—Vomiting—Carmustine—hematologic cancer	0.000269	0.000334	CcSEcCtD
Pentazocine—Insomnia—Triamcinolone—hematologic cancer	0.000268	0.000334	CcSEcCtD
Pentazocine—Agranulocytosis—Epirubicin—hematologic cancer	0.000268	0.000334	CcSEcCtD
Pentazocine—Dizziness—Vincristine—hematologic cancer	0.000267	0.000332	CcSEcCtD
Pentazocine—Dermatitis—Carmustine—hematologic cancer	0.000266	0.000331	CcSEcCtD
Pentazocine—Vomiting—Alitretinoin—hematologic cancer	0.000266	0.000331	CcSEcCtD
Pentazocine—Paraesthesia—Triamcinolone—hematologic cancer	0.000266	0.000331	CcSEcCtD
Pentazocine—Feeling abnormal—Prednisolone—hematologic cancer	0.000266	0.000331	CcSEcCtD
Pentazocine—Visual impairment—Methotrexate—hematologic cancer	0.000266	0.00033	CcSEcCtD
Pentazocine—Headache—Carmustine—hematologic cancer	0.000265	0.000329	CcSEcCtD
Pentazocine—Shock—Dexamethasone—hematologic cancer	0.000265	0.000329	CcSEcCtD
Pentazocine—Shock—Betamethasone—hematologic cancer	0.000265	0.000329	CcSEcCtD
Pentazocine—Dyspnoea—Triamcinolone—hematologic cancer	0.000264	0.000329	CcSEcCtD
Pentazocine—Agitation—Prednisone—hematologic cancer	0.000264	0.000328	CcSEcCtD
Pentazocine—Dermatitis—Alitretinoin—hematologic cancer	0.000264	0.000328	CcSEcCtD
Pentazocine—Vomiting—Ifosfamide—hematologic cancer	0.000263	0.000327	CcSEcCtD
Pentazocine—Hypersensitivity—Cisplatin—hematologic cancer	0.000263	0.000327	CcSEcCtD
Pentazocine—Tachycardia—Betamethasone—hematologic cancer	0.000263	0.000327	CcSEcCtD
Pentazocine—Tachycardia—Dexamethasone—hematologic cancer	0.000263	0.000327	CcSEcCtD
Pentazocine—Headache—Alitretinoin—hematologic cancer	0.000262	0.000326	CcSEcCtD
Pentazocine—Diarrhoea—Gemcitabine—hematologic cancer	0.000262	0.000326	CcSEcCtD
Pentazocine—Nausea—Thalidomide—hematologic cancer	0.000262	0.000325	CcSEcCtD
Pentazocine—Dermatitis—Ifosfamide—hematologic cancer	0.000261	0.000324	CcSEcCtD
Pentazocine—Erythema multiforme—Methotrexate—hematologic cancer	0.000261	0.000324	CcSEcCtD
Pentazocine—Hyperhidrosis—Dexamethasone—hematologic cancer	0.00026	0.000324	CcSEcCtD
Pentazocine—Hyperhidrosis—Betamethasone—hematologic cancer	0.00026	0.000324	CcSEcCtD
Pentazocine—Dizziness—Irinotecan—hematologic cancer	0.00026	0.000323	CcSEcCtD
Pentazocine—Vertigo—Prednisone—hematologic cancer	0.000258	0.000321	CcSEcCtD
Pentazocine—Syncope—Prednisone—hematologic cancer	0.000258	0.00032	CcSEcCtD
Pentazocine—Tinnitus—Methotrexate—hematologic cancer	0.000257	0.00032	CcSEcCtD
Pentazocine—Vomiting—Vincristine—hematologic cancer	0.000257	0.000319	CcSEcCtD
Pentazocine—Anorexia—Betamethasone—hematologic cancer	0.000257	0.000319	CcSEcCtD
Pentazocine—Anorexia—Dexamethasone—hematologic cancer	0.000257	0.000319	CcSEcCtD
Pentazocine—Asthenia—Cisplatin—hematologic cancer	0.000256	0.000318	CcSEcCtD
Pentazocine—Sweating—Doxorubicin—hematologic cancer	0.000255	0.000317	CcSEcCtD
Pentazocine—Dermatitis—Vincristine—hematologic cancer	0.000254	0.000316	CcSEcCtD
Pentazocine—Headache—Vincristine—hematologic cancer	0.000253	0.000315	CcSEcCtD
Pentazocine—Loss of consciousness—Prednisone—hematologic cancer	0.000252	0.000314	CcSEcCtD
Pentazocine—Hypotension—Betamethasone—hematologic cancer	0.000251	0.000313	CcSEcCtD
Pentazocine—Hypotension—Dexamethasone—hematologic cancer	0.000251	0.000313	CcSEcCtD
Pentazocine—Nausea—Carmustine—hematologic cancer	0.000251	0.000312	CcSEcCtD
Pentazocine—Vomiting—Mitoxantrone—hematologic cancer	0.00025	0.000311	CcSEcCtD
Pentazocine—Vomiting—Irinotecan—hematologic cancer	0.00025	0.000311	CcSEcCtD
Pentazocine—Nausea—Alitretinoin—hematologic cancer	0.000249	0.000309	CcSEcCtD
Pentazocine—Visual impairment—Epirubicin—hematologic cancer	0.000249	0.000309	CcSEcCtD
Pentazocine—Agranulocytosis—Doxorubicin—hematologic cancer	0.000248	0.000309	CcSEcCtD
Pentazocine—Hypertension—Prednisone—hematologic cancer	0.000248	0.000308	CcSEcCtD
Pentazocine—Dermatitis—Irinotecan—hematologic cancer	0.000248	0.000308	CcSEcCtD
Pentazocine—Dermatitis—Mitoxantrone—hematologic cancer	0.000248	0.000308	CcSEcCtD
Pentazocine—Chills—Methotrexate—hematologic cancer	0.000247	0.000308	CcSEcCtD
Pentazocine—Headache—Irinotecan—hematologic cancer	0.000246	0.000306	CcSEcCtD
Pentazocine—Headache—Mitoxantrone—hematologic cancer	0.000246	0.000306	CcSEcCtD
Pentazocine—Nausea—Ifosfamide—hematologic cancer	0.000246	0.000306	CcSEcCtD
Pentazocine—Feeling abnormal—Triamcinolone—hematologic cancer	0.000244	0.000304	CcSEcCtD
Pentazocine—Diarrhoea—Cisplatin—hematologic cancer	0.000244	0.000304	CcSEcCtD
Pentazocine—Erythema multiforme—Epirubicin—hematologic cancer	0.000244	0.000303	CcSEcCtD
Pentazocine—Vomiting—Gemcitabine—hematologic cancer	0.000243	0.000303	CcSEcCtD
Pentazocine—Insomnia—Dexamethasone—hematologic cancer	0.000243	0.000303	CcSEcCtD
Pentazocine—Insomnia—Betamethasone—hematologic cancer	0.000243	0.000303	CcSEcCtD
Pentazocine—Paraesthesia—Dexamethasone—hematologic cancer	0.000242	0.000301	CcSEcCtD
Pentazocine—Paraesthesia—Betamethasone—hematologic cancer	0.000242	0.000301	CcSEcCtD
Pentazocine—Dermatitis—Gemcitabine—hematologic cancer	0.000241	0.0003	CcSEcCtD
Pentazocine—Hypersensitivity—Etoposide—hematologic cancer	0.000241	0.0003	CcSEcCtD
Pentazocine—Tinnitus—Epirubicin—hematologic cancer	0.000241	0.000299	CcSEcCtD
Pentazocine—Headache—Gemcitabine—hematologic cancer	0.00024	0.000298	CcSEcCtD
Pentazocine—Nausea—Vincristine—hematologic cancer	0.00024	0.000298	CcSEcCtD
Pentazocine—Flushing—Epirubicin—hematologic cancer	0.000239	0.000298	CcSEcCtD
Pentazocine—Hypersensitivity—Prednisolone—hematologic cancer	0.000238	0.000296	CcSEcCtD
Pentazocine—Dysgeusia—Methotrexate—hematologic cancer	0.000235	0.000292	CcSEcCtD
Pentazocine—Asthenia—Etoposide—hematologic cancer	0.000235	0.000292	CcSEcCtD
Pentazocine—Anaphylactic shock—Prednisone—hematologic cancer	0.000234	0.000291	CcSEcCtD
Pentazocine—Decreased appetite—Dexamethasone—hematologic cancer	0.000234	0.000291	CcSEcCtD
Pentazocine—Decreased appetite—Betamethasone—hematologic cancer	0.000234	0.000291	CcSEcCtD
Pentazocine—Nausea—Mitoxantrone—hematologic cancer	0.000234	0.00029	CcSEcCtD
Pentazocine—Nausea—Irinotecan—hematologic cancer	0.000234	0.00029	CcSEcCtD
Pentazocine—Chills—Epirubicin—hematologic cancer	0.000231	0.000288	CcSEcCtD
Pentazocine—Pruritus—Etoposide—hematologic cancer	0.000231	0.000288	CcSEcCtD
Pentazocine—Shock—Prednisone—hematologic cancer	0.000231	0.000287	CcSEcCtD
Pentazocine—Visual impairment—Doxorubicin—hematologic cancer	0.00023	0.000286	CcSEcCtD
Pentazocine—Tachycardia—Prednisone—hematologic cancer	0.000229	0.000284	CcSEcCtD
Pentazocine—Nausea—Gemcitabine—hematologic cancer	0.000227	0.000283	CcSEcCtD
Pentazocine—Vomiting—Cisplatin—hematologic cancer	0.000227	0.000282	CcSEcCtD
Pentazocine—Hyperhidrosis—Prednisone—hematologic cancer	0.000227	0.000282	CcSEcCtD
Pentazocine—Vision blurred—Methotrexate—hematologic cancer	0.000226	0.000281	CcSEcCtD
Pentazocine—Erythema multiforme—Doxorubicin—hematologic cancer	0.000226	0.000281	CcSEcCtD
Pentazocine—Dermatitis—Cisplatin—hematologic cancer	0.000225	0.00028	CcSEcCtD
Pentazocine—Diarrhoea—Etoposide—hematologic cancer	0.000224	0.000278	CcSEcCtD
Pentazocine—Anorexia—Prednisone—hematologic cancer	0.000223	0.000278	CcSEcCtD
Pentazocine—Tinnitus—Doxorubicin—hematologic cancer	0.000223	0.000277	CcSEcCtD
Pentazocine—Feeling abnormal—Dexamethasone—hematologic cancer	0.000222	0.000276	CcSEcCtD
Pentazocine—Feeling abnormal—Betamethasone—hematologic cancer	0.000222	0.000276	CcSEcCtD
Pentazocine—Flushing—Doxorubicin—hematologic cancer	0.000222	0.000276	CcSEcCtD
Pentazocine—Dysgeusia—Epirubicin—hematologic cancer	0.00022	0.000274	CcSEcCtD
Pentazocine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000219	0.000272	CcSEcCtD
Pentazocine—Dizziness—Etoposide—hematologic cancer	0.000216	0.000269	CcSEcCtD
Pentazocine—Muscle spasms—Epirubicin—hematologic cancer	0.000216	0.000269	CcSEcCtD
Pentazocine—Vertigo—Methotrexate—hematologic cancer	0.000216	0.000268	CcSEcCtD
Pentazocine—Chills—Doxorubicin—hematologic cancer	0.000214	0.000266	CcSEcCtD
Pentazocine—Dizziness—Prednisolone—hematologic cancer	0.000213	0.000265	CcSEcCtD
Pentazocine—Asthenia—Triamcinolone—hematologic cancer	0.000213	0.000265	CcSEcCtD
Pentazocine—Nausea—Cisplatin—hematologic cancer	0.000212	0.000264	CcSEcCtD
Pentazocine—Insomnia—Prednisone—hematologic cancer	0.000212	0.000264	CcSEcCtD
Pentazocine—Vision blurred—Epirubicin—hematologic cancer	0.000212	0.000263	CcSEcCtD
Pentazocine—Paraesthesia—Prednisone—hematologic cancer	0.00021	0.000262	CcSEcCtD
Pentazocine—Pruritus—Triamcinolone—hematologic cancer	0.00021	0.000261	CcSEcCtD
Pentazocine—Vomiting—Etoposide—hematologic cancer	0.000208	0.000259	CcSEcCtD
Pentazocine—Agitation—Epirubicin—hematologic cancer	0.000206	0.000257	CcSEcCtD
Pentazocine—Dermatitis—Etoposide—hematologic cancer	0.000206	0.000256	CcSEcCtD
Pentazocine—Headache—Etoposide—hematologic cancer	0.000205	0.000255	CcSEcCtD
Pentazocine—Decreased appetite—Prednisone—hematologic cancer	0.000204	0.000253	CcSEcCtD
Pentazocine—Dysgeusia—Doxorubicin—hematologic cancer	0.000204	0.000253	CcSEcCtD
Pentazocine—Dermatitis—Prednisolone—hematologic cancer	0.000203	0.000253	CcSEcCtD
Pentazocine—Headache—Prednisolone—hematologic cancer	0.000202	0.000251	CcSEcCtD
Pentazocine—Vertigo—Epirubicin—hematologic cancer	0.000202	0.000251	CcSEcCtD
Pentazocine—Syncope—Epirubicin—hematologic cancer	0.000201	0.00025	CcSEcCtD
Pentazocine—Constipation—Prednisone—hematologic cancer	0.0002	0.000249	CcSEcCtD
Pentazocine—Muscle spasms—Doxorubicin—hematologic cancer	0.0002	0.000248	CcSEcCtD
Pentazocine—Confusional state—Methotrexate—hematologic cancer	0.000197	0.000246	CcSEcCtD
Pentazocine—Loss of consciousness—Epirubicin—hematologic cancer	0.000197	0.000246	CcSEcCtD
Pentazocine—Dizziness—Triamcinolone—hematologic cancer	0.000196	0.000244	CcSEcCtD
Pentazocine—Anaphylactic shock—Methotrexate—hematologic cancer	0.000196	0.000244	CcSEcCtD
Pentazocine—Vision blurred—Doxorubicin—hematologic cancer	0.000196	0.000244	CcSEcCtD
Pentazocine—Nausea—Etoposide—hematologic cancer	0.000194	0.000242	CcSEcCtD
Pentazocine—Hypertension—Epirubicin—hematologic cancer	0.000194	0.000241	CcSEcCtD
Pentazocine—Feeling abnormal—Prednisone—hematologic cancer	0.000193	0.00024	CcSEcCtD
Pentazocine—Asthenia—Betamethasone—hematologic cancer	0.000193	0.00024	CcSEcCtD
Pentazocine—Asthenia—Dexamethasone—hematologic cancer	0.000193	0.00024	CcSEcCtD
Pentazocine—Nausea—Prednisolone—hematologic cancer	0.000192	0.000238	CcSEcCtD
Pentazocine—Agitation—Doxorubicin—hematologic cancer	0.000191	0.000238	CcSEcCtD
Pentazocine—Pruritus—Betamethasone—hematologic cancer	0.00019	0.000237	CcSEcCtD
Pentazocine—Pruritus—Dexamethasone—hematologic cancer	0.00019	0.000237	CcSEcCtD
Pentazocine—Hyperhidrosis—Methotrexate—hematologic cancer	0.000189	0.000235	CcSEcCtD
Pentazocine—Vomiting—Triamcinolone—hematologic cancer	0.000189	0.000235	CcSEcCtD
Pentazocine—Dry mouth—Epirubicin—hematologic cancer	0.000187	0.000233	CcSEcCtD
Pentazocine—Dermatitis—Triamcinolone—hematologic cancer	0.000187	0.000232	CcSEcCtD
Pentazocine—Vertigo—Doxorubicin—hematologic cancer	0.000187	0.000232	CcSEcCtD
Pentazocine—Anorexia—Methotrexate—hematologic cancer	0.000187	0.000232	CcSEcCtD
Pentazocine—Syncope—Doxorubicin—hematologic cancer	0.000186	0.000232	CcSEcCtD
Pentazocine—Headache—Triamcinolone—hematologic cancer	0.000186	0.000231	CcSEcCtD
Pentazocine—Confusional state—Epirubicin—hematologic cancer	0.000185	0.00023	CcSEcCtD
Pentazocine—Diarrhoea—Dexamethasone—hematologic cancer	0.000184	0.000229	CcSEcCtD
Pentazocine—Diarrhoea—Betamethasone—hematologic cancer	0.000184	0.000229	CcSEcCtD
Pentazocine—Anaphylactic shock—Epirubicin—hematologic cancer	0.000183	0.000228	CcSEcCtD
Pentazocine—Hypotension—Methotrexate—hematologic cancer	0.000183	0.000228	CcSEcCtD
Pentazocine—Loss of consciousness—Doxorubicin—hematologic cancer	0.000183	0.000227	CcSEcCtD
Pentazocine—Shock—Epirubicin—hematologic cancer	0.00018	0.000224	CcSEcCtD
Pentazocine—Hypertension—Doxorubicin—hematologic cancer	0.000179	0.000223	CcSEcCtD
Pentazocine—Tachycardia—Epirubicin—hematologic cancer	0.000179	0.000222	CcSEcCtD
Pentazocine—Dizziness—Dexamethasone—hematologic cancer	0.000178	0.000221	CcSEcCtD
Pentazocine—Dizziness—Betamethasone—hematologic cancer	0.000178	0.000221	CcSEcCtD
Pentazocine—Hyperhidrosis—Epirubicin—hematologic cancer	0.000177	0.00022	CcSEcCtD
Pentazocine—Insomnia—Methotrexate—hematologic cancer	0.000177	0.00022	CcSEcCtD
Pentazocine—Nausea—Triamcinolone—hematologic cancer	0.000176	0.000219	CcSEcCtD
Pentazocine—Paraesthesia—Methotrexate—hematologic cancer	0.000176	0.000219	CcSEcCtD
Pentazocine—Anorexia—Epirubicin—hematologic cancer	0.000175	0.000217	CcSEcCtD
Pentazocine—Dyspnoea—Methotrexate—hematologic cancer	0.000175	0.000217	CcSEcCtD
Pentazocine—Somnolence—Methotrexate—hematologic cancer	0.000174	0.000217	CcSEcCtD
Pentazocine—Dry mouth—Doxorubicin—hematologic cancer	0.000173	0.000215	CcSEcCtD
Pentazocine—Hypersensitivity—Prednisone—hematologic cancer	0.000173	0.000215	CcSEcCtD
Pentazocine—Hypotension—Epirubicin—hematologic cancer	0.000171	0.000213	CcSEcCtD
Pentazocine—Vomiting—Betamethasone—hematologic cancer	0.000171	0.000213	CcSEcCtD
Pentazocine—Vomiting—Dexamethasone—hematologic cancer	0.000171	0.000213	CcSEcCtD
Pentazocine—Confusional state—Doxorubicin—hematologic cancer	0.000171	0.000213	CcSEcCtD
Pentazocine—Decreased appetite—Methotrexate—hematologic cancer	0.00017	0.000212	CcSEcCtD
Pentazocine—Anaphylactic shock—Doxorubicin—hematologic cancer	0.00017	0.000211	CcSEcCtD
Pentazocine—Dermatitis—Betamethasone—hematologic cancer	0.00017	0.000211	CcSEcCtD
Pentazocine—Dermatitis—Dexamethasone—hematologic cancer	0.00017	0.000211	CcSEcCtD
Pentazocine—Headache—Betamethasone—hematologic cancer	0.000169	0.00021	CcSEcCtD
Pentazocine—Headache—Dexamethasone—hematologic cancer	0.000169	0.00021	CcSEcCtD
Pentazocine—Asthenia—Prednisone—hematologic cancer	0.000168	0.000209	CcSEcCtD
Pentazocine—Shock—Doxorubicin—hematologic cancer	0.000167	0.000208	CcSEcCtD
Pentazocine—Pruritus—Prednisone—hematologic cancer	0.000166	0.000206	CcSEcCtD
Pentazocine—Insomnia—Epirubicin—hematologic cancer	0.000166	0.000206	CcSEcCtD
Pentazocine—Tachycardia—Doxorubicin—hematologic cancer	0.000166	0.000206	CcSEcCtD
Pentazocine—Paraesthesia—Epirubicin—hematologic cancer	0.000165	0.000205	CcSEcCtD
Pentazocine—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000164	0.000204	CcSEcCtD
Pentazocine—Dyspnoea—Epirubicin—hematologic cancer	0.000163	0.000203	CcSEcCtD
Pentazocine—Somnolence—Epirubicin—hematologic cancer	0.000163	0.000203	CcSEcCtD
Pentazocine—Anorexia—Doxorubicin—hematologic cancer	0.000162	0.000201	CcSEcCtD
Pentazocine—Feeling abnormal—Methotrexate—hematologic cancer	0.000161	0.000201	CcSEcCtD
Pentazocine—Diarrhoea—Prednisone—hematologic cancer	0.00016	0.000199	CcSEcCtD
Pentazocine—Nausea—Betamethasone—hematologic cancer	0.00016	0.000199	CcSEcCtD
Pentazocine—Nausea—Dexamethasone—hematologic cancer	0.00016	0.000199	CcSEcCtD
Pentazocine—Decreased appetite—Epirubicin—hematologic cancer	0.000159	0.000198	CcSEcCtD
Pentazocine—Hypotension—Doxorubicin—hematologic cancer	0.000158	0.000197	CcSEcCtD
Pentazocine—Constipation—Epirubicin—hematologic cancer	0.000157	0.000195	CcSEcCtD
Pentazocine—Dizziness—Prednisone—hematologic cancer	0.000155	0.000193	CcSEcCtD
Pentazocine—Insomnia—Doxorubicin—hematologic cancer	0.000153	0.000191	CcSEcCtD
Pentazocine—Paraesthesia—Doxorubicin—hematologic cancer	0.000152	0.000189	CcSEcCtD
Pentazocine—Dyspnoea—Doxorubicin—hematologic cancer	0.000151	0.000188	CcSEcCtD
Pentazocine—Feeling abnormal—Epirubicin—hematologic cancer	0.000151	0.000188	CcSEcCtD
Pentazocine—Somnolence—Doxorubicin—hematologic cancer	0.000151	0.000188	CcSEcCtD
Pentazocine—Vomiting—Prednisone—hematologic cancer	0.000149	0.000185	CcSEcCtD
Pentazocine—Dermatitis—Prednisone—hematologic cancer	0.000148	0.000184	CcSEcCtD
Pentazocine—Decreased appetite—Doxorubicin—hematologic cancer	0.000147	0.000183	CcSEcCtD
Pentazocine—Headache—Prednisone—hematologic cancer	0.000147	0.000183	CcSEcCtD
Pentazocine—Constipation—Doxorubicin—hematologic cancer	0.000145	0.00018	CcSEcCtD
Pentazocine—Hypersensitivity—Methotrexate—hematologic cancer	0.000144	0.000179	CcSEcCtD
Pentazocine—Asthenia—Methotrexate—hematologic cancer	0.000141	0.000175	CcSEcCtD
Pentazocine—Feeling abnormal—Doxorubicin—hematologic cancer	0.00014	0.000174	CcSEcCtD
Pentazocine—Nausea—Prednisone—hematologic cancer	0.000139	0.000173	CcSEcCtD
Pentazocine—Pruritus—Methotrexate—hematologic cancer	0.000139	0.000172	CcSEcCtD
Pentazocine—Hypersensitivity—Epirubicin—hematologic cancer	0.000135	0.000168	CcSEcCtD
Pentazocine—Diarrhoea—Methotrexate—hematologic cancer	0.000134	0.000167	CcSEcCtD
Pentazocine—Asthenia—Epirubicin—hematologic cancer	0.000132	0.000164	CcSEcCtD
Pentazocine—Pruritus—Epirubicin—hematologic cancer	0.00013	0.000161	CcSEcCtD
Pentazocine—Dizziness—Methotrexate—hematologic cancer	0.00013	0.000161	CcSEcCtD
Pentazocine—Diarrhoea—Epirubicin—hematologic cancer	0.000125	0.000156	CcSEcCtD
Pentazocine—Hypersensitivity—Doxorubicin—hematologic cancer	0.000125	0.000155	CcSEcCtD
Pentazocine—Vomiting—Methotrexate—hematologic cancer	0.000125	0.000155	CcSEcCtD
Pentazocine—Dermatitis—Methotrexate—hematologic cancer	0.000123	0.000153	CcSEcCtD
Pentazocine—Headache—Methotrexate—hematologic cancer	0.000123	0.000153	CcSEcCtD
Pentazocine—Asthenia—Doxorubicin—hematologic cancer	0.000122	0.000151	CcSEcCtD
Pentazocine—Dizziness—Epirubicin—hematologic cancer	0.000121	0.000151	CcSEcCtD
Pentazocine—Pruritus—Doxorubicin—hematologic cancer	0.00012	0.000149	CcSEcCtD
Pentazocine—Vomiting—Epirubicin—hematologic cancer	0.000117	0.000145	CcSEcCtD
Pentazocine—Nausea—Methotrexate—hematologic cancer	0.000116	0.000145	CcSEcCtD
Pentazocine—Diarrhoea—Doxorubicin—hematologic cancer	0.000116	0.000144	CcSEcCtD
Pentazocine—Dermatitis—Epirubicin—hematologic cancer	0.000115	0.000144	CcSEcCtD
Pentazocine—Headache—Epirubicin—hematologic cancer	0.000115	0.000143	CcSEcCtD
Pentazocine—Dizziness—Doxorubicin—hematologic cancer	0.000112	0.000139	CcSEcCtD
Pentazocine—Nausea—Epirubicin—hematologic cancer	0.000109	0.000135	CcSEcCtD
Pentazocine—Vomiting—Doxorubicin—hematologic cancer	0.000108	0.000134	CcSEcCtD
Pentazocine—Dermatitis—Doxorubicin—hematologic cancer	0.000107	0.000133	CcSEcCtD
Pentazocine—Headache—Doxorubicin—hematologic cancer	0.000106	0.000132	CcSEcCtD
Pentazocine—Nausea—Doxorubicin—hematologic cancer	0.000101	0.000125	CcSEcCtD
Pentazocine—OPRK1—GPCR downstream signaling—JAK2—hematologic cancer	4.47e-05	0.000243	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCR4—hematologic cancer	4.46e-05	0.000243	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HDAC2—hematologic cancer	4.46e-05	0.000243	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MAP2K1—hematologic cancer	4.45e-05	0.000242	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FOXO1—hematologic cancer	4.44e-05	0.000242	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—IL2—hematologic cancer	4.44e-05	0.000242	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PDGFRB—hematologic cancer	4.44e-05	0.000242	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GRB2—hematologic cancer	4.43e-05	0.000241	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CD—hematologic cancer	4.42e-05	0.000241	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PDGFA—hematologic cancer	4.41e-05	0.000241	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CB—hematologic cancer	4.39e-05	0.000239	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PDGFRA—hematologic cancer	4.37e-05	0.000238	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—JAK1—hematologic cancer	4.35e-05	0.000237	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCG—hematologic cancer	4.35e-05	0.000237	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KITLG—hematologic cancer	4.35e-05	0.000237	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CBL—hematologic cancer	4.35e-05	0.000237	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL3—hematologic cancer	4.3e-05	0.000234	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STAT5A—hematologic cancer	4.25e-05	0.000232	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CG—hematologic cancer	4.25e-05	0.000232	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CB—hematologic cancer	4.24e-05	0.000231	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTPN1—hematologic cancer	4.23e-05	0.00023	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CDKN2B—hematologic cancer	4.22e-05	0.00023	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PTPN11—hematologic cancer	4.17e-05	0.000228	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3R1—hematologic cancer	4.17e-05	0.000227	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RASGRP1—hematologic cancer	4.16e-05	0.000227	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HSP90AA1—hematologic cancer	4.15e-05	0.000226	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SYK—hematologic cancer	4.15e-05	0.000226	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CD—hematologic cancer	4.11e-05	0.000224	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CD86—hematologic cancer	4.08e-05	0.000222	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL2RA—hematologic cancer	4.07e-05	0.000222	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—JAK2—hematologic cancer	4.06e-05	0.000221	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CREB1—hematologic cancer	4.04e-05	0.00022	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL2—hematologic cancer	4.03e-05	0.00022	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HES1—hematologic cancer	4.02e-05	0.000219	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TERT—hematologic cancer	4.02e-05	0.000219	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NCOR1—hematologic cancer	4e-05	0.000218	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT1—hematologic cancer	4e-05	0.000218	CbGpPWpGaD
Pentazocine—EBP—Metabolism—AKT1—hematologic cancer	3.96e-05	0.000216	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL2—hematologic cancer	3.96e-05	0.000216	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CSF2—hematologic cancer	3.95e-05	0.000216	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGF1—hematologic cancer	3.95e-05	0.000216	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6R—hematologic cancer	3.94e-05	0.000215	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PDGFB—hematologic cancer	3.92e-05	0.000214	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FOXO1—hematologic cancer	3.9e-05	0.000212	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—IL2—hematologic cancer	3.9e-05	0.000212	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PDGFRB—hematologic cancer	3.89e-05	0.000212	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3R1—hematologic cancer	3.88e-05	0.000212	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CB—hematologic cancer	3.85e-05	0.00021	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TSC2—hematologic cancer	3.83e-05	0.000209	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PDGFRA—hematologic cancer	3.83e-05	0.000209	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—JAK1—hematologic cancer	3.82e-05	0.000208	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCG—hematologic cancer	3.82e-05	0.000208	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—JAK2—hematologic cancer	3.77e-05	0.000206	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MAP2K1—hematologic cancer	3.76e-05	0.000205	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GRB2—hematologic cancer	3.74e-05	0.000204	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CD—hematologic cancer	3.73e-05	0.000204	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PDGFA—hematologic cancer	3.73e-05	0.000203	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGFR3—hematologic cancer	3.69e-05	0.000201	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KITLG—hematologic cancer	3.68e-05	0.0002	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK14—hematologic cancer	3.65e-05	0.000199	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT5A—hematologic cancer	3.59e-05	0.000196	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	3.58e-05	0.000195	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ESR1—hematologic cancer	3.58e-05	0.000195	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL2RA—hematologic cancer	3.56e-05	0.000194	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CDKN2B—hematologic cancer	3.56e-05	0.000194	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FN1—hematologic cancer	3.54e-05	0.000193	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL2—hematologic cancer	3.54e-05	0.000193	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3R1—hematologic cancer	3.53e-05	0.000192	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TERT—hematologic cancer	3.52e-05	0.000192	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—BAD—hematologic cancer	3.5e-05	0.000191	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NFKBIA—hematologic cancer	3.5e-05	0.000191	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOTCH1—hematologic cancer	3.46e-05	0.000189	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CD86—hematologic cancer	3.45e-05	0.000188	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PDGFB—hematologic cancer	3.44e-05	0.000188	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—JAK2—hematologic cancer	3.43e-05	0.000187	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HES1—hematologic cancer	3.4e-05	0.000185	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CD80—hematologic cancer	3.39e-05	0.000185	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CG—hematologic cancer	3.39e-05	0.000185	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KIT—hematologic cancer	3.39e-05	0.000185	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—NRAS—hematologic cancer	3.39e-05	0.000185	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NCOR1—hematologic cancer	3.38e-05	0.000184	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TSC2—hematologic cancer	3.36e-05	0.000183	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CSF2—hematologic cancer	3.34e-05	0.000182	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGF1—hematologic cancer	3.34e-05	0.000182	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTPN11—hematologic cancer	3.33e-05	0.000181	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FOXO1—hematologic cancer	3.29e-05	0.00018	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—IL2—hematologic cancer	3.29e-05	0.000179	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PDGFRB—hematologic cancer	3.29e-05	0.000179	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CB—hematologic cancer	3.26e-05	0.000177	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MAPK3—hematologic cancer	3.24e-05	0.000177	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PDGFRA—hematologic cancer	3.24e-05	0.000176	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGFR3—hematologic cancer	3.23e-05	0.000176	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—JAK1—hematologic cancer	3.23e-05	0.000176	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCG—hematologic cancer	3.23e-05	0.000176	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CREB1—hematologic cancer	3.22e-05	0.000176	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK14—hematologic cancer	3.2e-05	0.000175	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—BRAF—hematologic cancer	3.18e-05	0.000174	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL2—hematologic cancer	3.15e-05	0.000172	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6R—hematologic cancer	3.14e-05	0.000171	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ESR1—hematologic cancer	3.14e-05	0.000171	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CREBBP—hematologic cancer	3.14e-05	0.000171	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FN1—hematologic cancer	3.1e-05	0.000169	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NFKBIA—hematologic cancer	3.07e-05	0.000167	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—BAD—hematologic cancer	3.07e-05	0.000167	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOTCH1—hematologic cancer	3.04e-05	0.000166	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL2RA—hematologic cancer	3.01e-05	0.000164	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAP2K1—hematologic cancer	3e-05	0.000163	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL2—hematologic cancer	2.99e-05	0.000163	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TERT—hematologic cancer	2.98e-05	0.000162	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CD—hematologic cancer	2.98e-05	0.000162	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CD80—hematologic cancer	2.97e-05	0.000162	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KIT—hematologic cancer	2.97e-05	0.000162	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CG—hematologic cancer	2.97e-05	0.000162	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—NRAS—hematologic cancer	2.97e-05	0.000162	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.95e-05	0.000161	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTPN11—hematologic cancer	2.92e-05	0.000159	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—KRAS—hematologic cancer	2.91e-05	0.000159	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	2.91e-05	0.000158	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGF2—hematologic cancer	2.85e-05	0.000155	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MAPK3—hematologic cancer	2.84e-05	0.000155	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TSC2—hematologic cancer	2.84e-05	0.000155	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CREB1—hematologic cancer	2.83e-05	0.000154	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3R1—hematologic cancer	2.81e-05	0.000153	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—BRAF—hematologic cancer	2.79e-05	0.000152	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL2—hematologic cancer	2.77e-05	0.000151	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6R—hematologic cancer	2.76e-05	0.00015	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CREBBP—hematologic cancer	2.75e-05	0.00015	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	2.73e-05	0.000149	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—JAK2—hematologic cancer	2.73e-05	0.000149	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	2.71e-05	0.000148	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CA—hematologic cancer	2.68e-05	0.000146	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MDM2—hematologic cancer	2.67e-05	0.000145	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ESR1—hematologic cancer	2.65e-05	0.000145	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAP2K1—hematologic cancer	2.63e-05	0.000143	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FN1—hematologic cancer	2.62e-05	0.000143	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CD—hematologic cancer	2.61e-05	0.000142	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CB—hematologic cancer	2.59e-05	0.000141	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MTOR—hematologic cancer	2.59e-05	0.000141	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—BAD—hematologic cancer	2.59e-05	0.000141	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	2.59e-05	0.000141	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.59e-05	0.000141	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	2.57e-05	0.00014	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—KRAS—hematologic cancer	2.56e-05	0.000139	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CD80—hematologic cancer	2.51e-05	0.000137	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	2.51e-05	0.000137	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KIT—hematologic cancer	2.51e-05	0.000137	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	2.51e-05	0.000137	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGF2—hematologic cancer	2.5e-05	0.000136	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HRAS—hematologic cancer	2.48e-05	0.000135	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	2.47e-05	0.000134	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3R1—hematologic cancer	2.47e-05	0.000134	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CDKN1B—hematologic cancer	2.44e-05	0.000133	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AKT1—hematologic cancer	2.41e-05	0.000131	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	2.4e-05	0.000131	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—JAK2—hematologic cancer	2.4e-05	0.000131	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CREB1—hematologic cancer	2.39e-05	0.00013	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CASP3—hematologic cancer	2.39e-05	0.00013	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL2—hematologic cancer	2.38e-05	0.00013	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—hematologic cancer	2.37e-05	0.000129	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—BRAF—hematologic cancer	2.36e-05	0.000129	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CA—hematologic cancer	2.35e-05	0.000128	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MDM2—hematologic cancer	2.34e-05	0.000127	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL2—hematologic cancer	2.34e-05	0.000127	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6R—hematologic cancer	2.33e-05	0.000127	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	2.33e-05	0.000127	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCND1—hematologic cancer	2.32e-05	0.000127	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—JUN—hematologic cancer	2.32e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	2.28e-05	0.000124	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MTOR—hematologic cancer	2.28e-05	0.000124	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CDKN1A—hematologic cancer	2.25e-05	0.000123	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTEN—hematologic cancer	2.24e-05	0.000122	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	2.22e-05	0.000121	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	2.21e-05	0.00012	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	2.19e-05	0.00012	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	2.19e-05	0.000119	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.19e-05	0.000119	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	2.17e-05	0.000118	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	2.16e-05	0.000118	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EP300—hematologic cancer	2.14e-05	0.000117	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	2.14e-05	0.000116	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGF2—hematologic cancer	2.11e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	2.11e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CASP3—hematologic cancer	2.09e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL2—hematologic cancer	2.09e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	2.08e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SRC—hematologic cancer	2.08e-05	0.000113	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—hematologic cancer	2.08e-05	0.000113	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCND1—hematologic cancer	2.04e-05	0.000111	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—JUN—hematologic cancer	2.03e-05	0.000111	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	2.03e-05	0.00011	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—JAK2—hematologic cancer	2.02e-05	0.00011	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STAT3—hematologic cancer	2.01e-05	0.000109	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NRAS—hematologic cancer	2e-05	0.000109	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	1.98e-05	0.000108	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MDM2—hematologic cancer	1.98e-05	0.000108	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	1.97e-05	0.000107	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTEN—hematologic cancer	1.97e-05	0.000107	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	1.92e-05	0.000105	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MTOR—hematologic cancer	1.92e-05	0.000105	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	1.92e-05	0.000105	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	1.92e-05	0.000105	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	1.92e-05	0.000104	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EP300—hematologic cancer	1.88e-05	0.000102	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MYC—hematologic cancer	1.86e-05	0.000102	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	1.86e-05	0.000101	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	1.84e-05	0.0001	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SRC—hematologic cancer	1.82e-05	9.94e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	1.8e-05	9.84e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	1.79e-05	9.73e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	1.78e-05	9.68e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CASP3—hematologic cancer	1.77e-05	9.64e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL2—hematologic cancer	1.77e-05	9.63e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STAT3—hematologic cancer	1.76e-05	9.59e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—hematologic cancer	1.76e-05	9.58e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NRAS—hematologic cancer	1.75e-05	9.56e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KRAS—hematologic cancer	1.72e-05	9.39e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCND1—hematologic cancer	1.72e-05	9.38e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—JUN—hematologic cancer	1.72e-05	9.37e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	1.68e-05	9.16e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	1.67e-05	9.08e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTEN—hematologic cancer	1.66e-05	9.06e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MYC—hematologic cancer	1.63e-05	8.91e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	1.63e-05	8.89e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	1.63e-05	8.86e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	1.62e-05	8.84e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EP300—hematologic cancer	1.58e-05	8.64e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	1.58e-05	8.62e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SRC—hematologic cancer	1.54e-05	8.4e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TP53—hematologic cancer	1.53e-05	8.34e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KRAS—hematologic cancer	1.51e-05	8.23e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	1.5e-05	8.18e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT3—hematologic cancer	1.49e-05	8.1e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NRAS—hematologic cancer	1.48e-05	8.08e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HRAS—hematologic cancer	1.46e-05	7.98e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	1.42e-05	7.74e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—hematologic cancer	1.4e-05	7.64e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	1.39e-05	7.56e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MYC—hematologic cancer	1.38e-05	7.53e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	1.38e-05	7.51e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TP53—hematologic cancer	1.34e-05	7.31e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT1—hematologic cancer	1.29e-05	7.04e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HRAS—hematologic cancer	1.28e-05	7e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KRAS—hematologic cancer	1.28e-05	6.96e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—hematologic cancer	1.23e-05	6.7e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	1.17e-05	6.39e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TP53—hematologic cancer	1.13e-05	6.18e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT1—hematologic cancer	1.13e-05	6.18e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HRAS—hematologic cancer	1.08e-05	5.91e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—hematologic cancer	1.04e-05	5.66e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT1—hematologic cancer	9.58e-06	5.22e-05	CbGpPWpGaD
